Results 161 to 170 of about 7,727 (171)

The cross-talk and interplay between ferroptosis and cuproptosis in tumor and therapeutics. [PDF]

Cell Oncol (Dordr)
Zhou X, Peng S.
europepmc   +1 more source

Cuproptosis-triggering nanomedicine boosts antitumor immunotherapy. [PDF]

Theranostics
Wang M, Shi C, Shu Z, Li Z.
europepmc   +1 more source

A precise theranostic nanoplatform amplifies anti-tumor efficacy via copper ionophores and sonodynamic therapy. [PDF]

Mater Today Bio
Luo X, Wang X, Li S, Chen Q, Song J, Chen J.   +5 more
europepmc   +1 more source

Thermoradiotherapy-Driven Enhancement of Cuproptosis by Copper-Nitroimidazole Based Nanoparticles. [PDF]

Int J Nanomedicine
Yang D, Tao L, Li Q, Ning S, Song Y.
europepmc   +1 more source

Role of cuproptosis in digestive system tumors (Review). [PDF]

Int J Mol Med
Zhang L, Cheng Y, Tang L, Zhu J, Tuo B.
europepmc   +1 more source

Bimetallic Cu/Fe-MOF-based heterojunction sonozymes for triple amplification of sono-immunotherapy through activating tumor-specific cuproptosis and cGAS-STING pathway. [PDF]

Theranostics
Liu X, Wang N, Cai J, Hu J, Zhang Z, Feng C, Pan D, Geng B.   +7 more
europepmc   +1 more source

METTL3-mediated m6A modification of FDX1 confers resistance to cuproptosis and promotes hepatocellular carcinoma progression. [PDF]

Commun Biol
Jiang Q, Peng C, Mao W, Yu Z, Feng Y, Li Y, Zhu J, Zhao J, Liao D, Sun T.   +9 more
europepmc   +1 more source

Effect of EGR1/LIPT1 regulatory axis on cuproptosis in chromophobe renal cell carcinoma. [PDF]

Brief Funct Genomics
Luo J, Su M, Li X, Ye D, Zeng X, Wang Y, Fu G.   +6 more
europepmc   +1 more source

A mitochondrion-targeted natural polyphenolic copper carrier overcomes tumor resistance to cisplatin by potentiating cuproptosis. [PDF]

J Exp Clin Cancer Res
Yang H, Xiong X, Chen X, Huang S, Dai H, Yuan L, Fan J, Xiang Z, Wang W, Qin Y.   +9 more
europepmc   +1 more source